QED Investigative Site
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Peng, Yong Wei
MYCHELANGELO I, NCT05497453: A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

Terminated
1/2
24
US, RoW
OTX-2002, Tyrosine kinase inhibitor One, Tyrosine kinase inhibitor Two, Checkpoint Inhibitor, Immune
Omega Therapeutics
Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Hepatocellular Cancer, Liver Cancer, Liver, Cancer Of, Non-Resectable
11/24
11/24
CHAPTER-GIST-101, NCT05245968: A Study of Pimitespib in Combination with Imatinib in Patients with GIST

Recruiting
1
78
Japan, RoW
Pimitespib, TAS-116, Imatinib, Sunitinib
Taiho Pharmaceutical Co., Ltd.
Gastrointestinal Stromal Tumors
12/25
12/25
EBC-129-01, NCT05701527: A Study of EBC-129 in Advanced Solid Tumours

Recruiting
1
84
US, RoW
EBC-129, Pembrolizumab
EDDC (Experimental Drug Development Centre), A*STAR Research Entities, Parexel
Advanced Solid Tumours
06/26
06/26
PLACARD, NCT06336239: PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

Recruiting
N/A
3000
RoW
Beijing Anzhen Hospital
Cardiovascular Disease, Type 2 Diabetes Mellitus
07/24
12/24
Xenier, Lau Xinyi
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Peng, Yong Wei
MYCHELANGELO I, NCT05497453: A Phase 1/2 Study to Evaluate OTX-2002 in Patients with Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association with the MYC Oncogene

Terminated
1/2
24
US, RoW
OTX-2002, Tyrosine kinase inhibitor One, Tyrosine kinase inhibitor Two, Checkpoint Inhibitor, Immune
Omega Therapeutics
Hepatocellular Carcinoma, Solid Tumor, Hepatocellular Carcinoma Non-resectable, Hepatocellular Carcinoma Recurrent, Hepatocellular Cancer, Liver Cancer, Liver, Cancer Of, Non-Resectable
11/24
11/24
CHAPTER-GIST-101, NCT05245968: A Study of Pimitespib in Combination with Imatinib in Patients with GIST

Recruiting
1
78
Japan, RoW
Pimitespib, TAS-116, Imatinib, Sunitinib
Taiho Pharmaceutical Co., Ltd.
Gastrointestinal Stromal Tumors
12/25
12/25
EBC-129-01, NCT05701527: A Study of EBC-129 in Advanced Solid Tumours

Recruiting
1
84
US, RoW
EBC-129, Pembrolizumab
EDDC (Experimental Drug Development Centre), A*STAR Research Entities, Parexel
Advanced Solid Tumours
06/26
06/26
PLACARD, NCT06336239: PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study

Recruiting
N/A
3000
RoW
Beijing Anzhen Hospital
Cardiovascular Disease, Type 2 Diabetes Mellitus
07/24
12/24
Xenier, Lau Xinyi
No trials found

Download Options